Home Compare CVS vs HUM
Stock Comparison · Industry comparison · Healthcare Plans

CVS Health vs Humana: Which Stock Looks Stronger in 2026?

Humana leads structurally, with valuation as the clearest single gap between the two profiles. CVS Health still has the edge on growth, which keeps the comparison from looking entirely one-sided. The market setup is currently leaning toward CVS Health, which does not confirm the structural lead. That leaves a split case: the structural lead stays with Humana, but the market is not currently confirming it.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The comparison is mainly decided in valuation, with the rest of the profile carrying less weight. Humana Inc. leads by 11 points on the overall comparison score.

INDUSTRY COMPARISON

Both operate in: Healthcare Plans

This comparison is based on industry proximity, not on functional trajectory similarity. CVS and HUM share the same industry classification.

For a similarity-based comparison, see how CVS Health and Humana each position within their functional peer groups in AssetNext.

Peer-Relative Score
CVS
CVS Health Corporation
40
Peer-Score
Signal qualityMedium
vs
HUM
Humana Inc.
51
Peer-Score
Signal qualityMedium

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Pricing shapes this comparison more than a broad operating gap.

Dimension spread: CVS vs HUM Profitability 31 40 Stability 39 33 Valuation 35 80 Growth 60 40 CVS HUM
Gap Ranking
#1 Valuation +45
#2 Growth +20
#3 Profitability +9
#4 Stability +6
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for CVS and HUM Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer CVSHUM Relative valuation Structural strength

The two profiles are relatively close, but the price setup still leans toward Humana Inc..

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Valuation
Humana Inc. ranks near the top of the group on valuation; CVS Health Corporation sits in the weaker half.
Growth
On growth, the edge still sits with CVS Health Corporation, even though both profiles look solid.
Valuation — Dominant Gap
CVS
35
HUM
80
Gap+45in favour of HUM

The multiple-based pricing edge comes from a trailing P/E that is 32 turns lower.

What keeps the gap from being one-sided

Earnings growth also leans the other way, which keeps the score lead from reading as a full growth sweep.

What this means for the comparison

Valuation settles the comparison, while pricing and growth keep the broader setup from looking fully aligned.

Explore full peer positioning in AssetNext

Break down the CVS vs HUM comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how CVS and HUM each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.